Cite

HARVARD Citation

    Tfelt-Hansen, P. et al. (2020). Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review. Cephalalgia. pp. 122-126. [Online]. 
  
Back to record